| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Biological and Medical Research Division, Argonne National Laboratory, Argonne, IL 60439
Genistein, an in vitro inhibitor of topoisomerase II and tyrosine kinases, suppressed growth and induced differentiation in HL-205 cells, a clonal population of the human promyelocytic HL-60 leukemia cells, and in K-562-J cells, a clonal population of the human erythroid K-562 leukemia cells. Maturing HL-205 cells acquired either granulocytic or monocytic markers, namely, reactivity with the murine OKM1 monoclonal antibody, expression of nitroblue tetrazolium dye reduction, and staining for nonspecific esterase. The maturing K-562-J cells stained with benzidine, which indicates the presence of hemoglobin, an erythroid maturation marker. Although the acquisition of the maturation markers in both HL-205 and K-562-J cells was time dependent up to 6 days, the kinetics of this induction differed between the two cell types. Despite the in vitro inhibitory effect of genistein, treatment of either HL-205 or K-562-J cells with 150 µg/ml genistein for up to 16 h did not alter topoisomerase II activity (as determined by the unknotting assay) in their nuclear extracts. Analysis with the anti-phosphotyrosine PY-20 murine monoclonal antibody indicated that treatment of K-562-J cells with genistein decreased the reactivity of the antibody with two of the cellular proteins. However, no reactivity with the PY-20 antibody was detected in untreated or genistein-treated HL-205 cells. An early event in the HL-205 and K-562-J cells, occurring after only 1 h of treatment with 30200 µg/ml genistein, was the induction of DNA damage as measured by an alkaline elution assay. This damage may be a contributing factor in the genistein-induced cell differentiation in the HL-205 and K-562-J cells.
1 This work was supported by the U.S. Department of Energy, Office of Health and Environmental Research, under contract W-31-109-ENG-38.
2 To whom requests for reprints should be addressed, at Biological and Medical Research Division, Argonne National Laboratory, 9700 South Cass Avenue, Argonne, IL 60439.
Received 8/11/89.
Revised 12/20/89.
This article has been cited by other articles:
![]() |
M. Messina, W. McCaskill-Stevens, and J. W. Lampe Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings. J Natl Cancer Inst, September 20, 2006; 98(18): 1275 - 1284. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Gilliland, C. T. Jordan, and C. A. Felix The Molecular Basis of Leukemia Hematology, January 1, 2004; 2004(1): 80 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wei, R. Saladi, Y. Lu, Y. Wang, S. R. Palep, J. Moore, R. Phelps, E. Shyong, and M. G. Lebwohl Isoflavone Genistein: Photoprotection and Clinical Implications in Dermatology J. Nutr., November 1, 2003; 133(11): 3811S - 3819. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Piersen Phytoestrogens in Botanical Dietary Supplements: Implications for Cancer Integr Cancer Ther, June 1, 2003; 2(2): 120 - 138. [Abstract] [PDF] |
||||
![]() |
Y. Li and F. H. Sarkar Inhibition of Nuclear Factor {kappa}B Activation in PC3 Cells by Genistein Is Mediated via Akt Signaling Pathway Clin. Cancer Res., July 1, 2002; 8(7): 2369 - 2377. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Messina and C. L. Loprinzi Soy for Breast Cancer Survivors: A Critical Review of the Literature J. Nutr., November 1, 2001; 131(11): 3095S - 3108. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-J. W. Lu, K. E. Anderson, J. J. Grady, and M. Nagamani Effects of an Isoflavone-Free Soy Diet on Ovarian Hormones in Premenopausal Women J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3045 - 3052. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Middleton Jr., C. Kandaswami, and T. C. Theoharides The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer Pharmacol. Rev., December 1, 2000; 52(4): 673 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Darbon, M. Penary, N. Escalas, F. Casagrande, F. Goubin-Gramatica, C. Baudouin, and B. Ducommun Distinct Chk2 Activation Pathways Are Triggered by Genistein and DNA-damaging Agents in Human Melanoma Cells J. Biol. Chem., May 12, 2000; 275(20): 15363 - 15369. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J Messina Legumes and soybeans: overview of their nutritional profiles and health effects Am. J. Clinical Nutrition, September 1, 1999; 70(3): 439S - 450. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gozlan, J. L. Lathey, and S. A. Spector Human Immunodeficiency Virus Type 1 Induction Mediated by Genistein Is Linked to Cell Cycle Arrest in G2 J. Virol., October 1, 1998; 72(10): 8174 - 8180. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wu, H. Huang, Z. Miner, and M. Kulesz-Martin Activities and response to DNA damage of latent and active sequence-specific DNA binding forms of mouse p53 PNAS, August 19, 1997; 94(17): 8982 - 8987. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Vera, A. M. Reyes, J. G. Cárcamo, F. V. Velásquez, C. I. Rivas, R. H. Zhang, P. Strobel, R. Iribarren, H. I. Scher, J. C. Slebe, et al. Genistein Is a Natural Inhibitor of Hexose and Dehydroascorbic Acid Transport through the Glucose Transporter, GLUT1 J. Biol. Chem., April 12, 1996; 271(15): 8719 - 8724. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.-S. Chang and N. S. Chang Transforming Growth Factor-beta1 Induction of Novel Extracellular Matrix Proteins That Trigger Resistance to Tumor Necrosis Factor Cytotoxicity in Murine L929 Fibroblasts J. Biol. Chem., March 31, 1995; 270(13): 7765 - 7772. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Strick, P. L. Strissel, S. Borgers, S. L. Smith, and J. D. Rowley From the Cover: Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia PNAS, April 25, 2000; 97(9): 4790 - 4795. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |